The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Bruno García del Blanco
Showing 1-9 of 9 articles
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabaté M
August 5, 2022 | 10.4244/EIJ-D-21-00651
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial
Sabaté M,
Jensen L,
Tilsted H,
Moreno R,
García del Blanco B,
Macaya C,
Perez de Prado A,
Cequier A,
Pérez-Fuentes P,
Schütte D,
Costa R,
Stoll H,
Lassen J
June 25, 2021 | 10.4244/EIJ-D-20-01162
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J,
Ortega-Paz L,
Brugaletta S,
Cuesta J,
Romaní S,
Serra A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Antuña P,
Romaguera R,
Regueiro A,
Rivero F,
Cequier A,
Alfonso F,
Gómez-Hospital JA,
Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial
Moreu J,
Moreno-Gómez R,
Perez de Prado A,
García del Blanco B,
Trillo R,
Pinar E,
Molina E,
Zueco J,
Merchán A,
Díaz-Fernández J,
Amat I
December 20, 2019 | 10.4244/EIJ-D-19-00206
Spain: coronary and structural heart interventions from 2010 to 2015
García del Blanco B,
Jiménez-Quevedo P,
Diaz J,
Hernandez F,
Rumoroso J-R,
Sabaté M,
de la Torre Hernandez J,
Serrador A,
Perez de Prado A,
Goicolea J,
Trillo R,
Pan M
May 15, 2017 | 10.4244/EIJ-D-16-00834
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)
Garcia-Touchard A,
Goicolea J,
Sabaté M,
Alfonso F,
Ruiz-Salmeron R,
Bethencourt A,
Gonzalo N,
Miranda F,
García del Blanco B,
Jimenez Mazuecos J,
Melgares R,
Martinez-Romero P,
Hernandez-Garcia J,
Lezaun R,
Bullones J,
Fernandez Portales J,
Rumoroso J-R,
Ortas R,
Valdes M,
Trillo R,
Brugaletta S,
Otzuki S,
Hernández Pérez FJ,
Alonso-Pulpón L
January 20, 2017 | 10.4244/EIJ-D-16-00128
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
Alfonso F,
Pérez-Vizcayno M,
Cardenas A,
García del Blanco B,
García Touchard A,
Lopez-Minguez J,
Rivero F,
Masotti M,
Zueco J,
Cequier A,
Morís C,
Fernandez Ortiz A,
Escaned J,
Jiménez-Quevedo P,
Gonzalo N,
Fernandez C,
Macaya C
July 20, 2015 | 10.4244/EIJY14M09_07
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial
Costa R,
Abizaid A,
Abizaid An,
García del Blanco B,
Berland J,
Petrov I,
Brenot P,
van Geuns R,
Royer T,
Rubino P,
Lesiak M,
Fajadet J
March 21, 2012 | 10.4244/EIJV7I11A205
Clinical and procedural evaluation of the Nile Croco® dedicated stent for bifurcations: a single centre experience with the first 151 consecutive non-selected patients
García del Blanco B,
Martí G,
Bellera N,
Otaegui I,
Serra V,
Ferreira I,
Domingo E,
Angel J,
Candell J,
García-Dorado D
June 30, 2011 | 10.4244/EIJV7I2A36
1
Latest news
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022
NEW
EuroIntervention's new Impact Factor!
June 28, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke